Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PLX

Pyrolyx (PLX)

Pyrolyx AG
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:PLX
DateTimeSourceHeadlineSymbolCompany
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest EliminationsTSXV:PLXProtalix BioTherapeutics Inc.
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-TSXV:PLXProtalix BioTherapeutics Inc.
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-TSXV:PLXProtalix BioTherapeutics Inc.
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesTSXV:PLXProtalix BioTherapeutics Inc.
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesTSXV:PLXProtalix BioTherapeutics Inc.
11/15/20137:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-TSXV:PLXProtalix BioTherapeutics Inc.
02/05/20135:43PMDow Jones NewsU.S. HOT STOCKS: Zynga, Take-Two, Shutterfly Active in Late TradingTSXV:PLXProtalix BioTherapeutics Inc.
02/05/20131:21PMDow Jones NewsU.S. HOT STOCKS: Yum Brands, McGraw-Hill, Virgin Media, OpexaTSXV:PLXProtalix BioTherapeutics Inc.
02/05/201311:40AMDow Jones NewsProtalix Confirms It's Considering Options; Shares SurgeTSXV:PLXProtalix BioTherapeutics Inc.
06/11/20127:29AMDow Jones NewsProtalix Gets $25 Million Milestone Payment For Rare-Disease DrugTSXV:PLXProtalix BioTherapeutics Inc.
05/01/20125:05PMDow Jones NewsUPDATE: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseTSXV:PLXProtalix BioTherapeutics Inc.
05/01/20124:37PMDow Jones NewsCORRECT: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseTSXV:PLXProtalix BioTherapeutics Inc.
05/01/20124:07PMDow Jones NewsFDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseTSXV:PLXProtalix BioTherapeutics Inc.
10/15/200910:50AMDow Jones NewsUPDATE: Protalix Gaucher's Treatment Passes Late-Stage TrialTSXV:PLXProtalix BioTherapeutics Inc.
10/15/20095:56AMDow Jones NewsProtalix Gaucher's Treatment Passes Late-Stage TrialTSXV:PLXProtalix BioTherapeutics Inc.
08/31/20091:39PMDow Jones NewsGenzyme Top Seller Faces Competition Amid Supply IssuesTSXV:PLXProtalix BioTherapeutics Inc.
08/25/20098:06AMDow Jones NewsFDA Gives Fast-Track Status To Protalix Drug For Gaucher'sTSXV:PLXProtalix BioTherapeutics Inc.
08/17/20097:35AMDow Jones NewsFDA OKs Protalix's Treatment Protocol Drug For Gaucher DiseaseTSXV:PLXProtalix BioTherapeutics Inc.
08/03/200910:54AMDow Jones NewsIcagen Rallies, Genzyme Slides On FDA UpdatesTSXV:PLXProtalix BioTherapeutics Inc.
08/03/20092:05AMDow Jones NewsShire Says FDA Permits Vela Use; Reports Phase III SuccessTSXV:PLXProtalix BioTherapeutics Inc.
07/16/20094:12AMDow Jones NewsUPDATE: Shire Gets Fast-Track Approval For Gaucher-Treating DrugTSXV:PLXProtalix BioTherapeutics Inc.
07/16/20092:25AMDow Jones NewsShire Gets Fast-Track Approval For Gaucher-Treating DrugTSXV:PLXProtalix BioTherapeutics Inc.
07/07/20094:11AMDow Jones NewsUPDATE:Shire Seeks FDA OK To Provide Vela Amid Drug ShortageTSXV:PLXProtalix BioTherapeutics Inc.
 Showing the most relevant articles for your search:ASX:PLX